Find investors
← Back to all investors
SC
ResearchedAngel Investors

Simon Cai

Senior Associate

Angel InvestorsSeed Round
Pitch Simon

Get their honest, personalized take on your startup.

Sign in to pitch Simon

At a glance

Full Name
Simon Cai
Title
Principal (previously Vice President; joined as an associate/senior associate) — Investment Team
Firm
Penfund
Firm Type
Private capital / direct lending firm — provider of senior and junior (mezzanine) capital to middle-market companies (not an angel investor)
Investment Stage
Established, cash-generative middle-market companies (buyouts, recapitalizations, acquisitions, shareholder liquidity, growth) — not seed/startup stage
Check Size
Up to C$225 million per transaction; can hold up to ~C$300 million (or USD equivalent) hold-to-maturity
Target Company Profile
Middle-market businesses typically generating at least ~US$20 million of annual EBITDA; asset-light companies that convert 80–90% of EBITDA to free cash flow, often selling non-discretionary, non-deferrable consumable goods/services
Sector Focus
Sector-agnostic, with activity across consumer services, business services, healthcare, and financial/industrial services
Geographic Focus
North America (Canada and the United States)
Location
Toronto, Ontario, Canada (333 Bay Street, Suite 610)

Background

Simon Cai is a member of the investment team at Penfund, a Toronto-based private capital firm founded in 1979 that provides senior and junior capital to middle-market companies across North America. He joined Penfund in 2018 and has risen through the firm's investment ranks — he was promoted to Vice President effective April 1, 2022, and is now listed as a Principal at the firm. His work centers on originating, underwriting, and managing Penfund's debt and structured-capital investments, which are deployed through vehicles such as Penfund Prime (senior direct lending) and the Penfund Capital Fund series (junior/mezzanine capital).

Before Penfund, Cai worked in the Real Estate Investment Banking Group at BMO Capital Markets and in the Infrastructure Advisory Group at Deloitte LLP, giving him a background spanning M&A/financing advisory and structured infrastructure finance. He holds a Bachelor of Commerce and a Bachelor of Science in Mathematics, both from Queen's University, and is a CFA charterholder.

It is worth flagging that the original stub data ("Angel Investors / Seed Round / Senior Associate") does not match verifiable sources. Penfund is a middle-market private credit and junior-capital firm — not an angel or seed-stage investor — and Cai's current title is Principal. Founders seeking pre-seed or seed equity are not Penfund's target; the firm finances mature, cash-flow-positive companies with meaningful EBITDA.

Penfund has deployed more than C$4.3 billion across roughly 75 investments since 2000, with assets and capital under management exceeding C$3.5 billion sourced from pension funds, insurance companies, banks, family offices, and high-net-worth investors in Canada, the U.S., the Middle East, and Europe.

Investment Thesis & Focus

  • What Penfund funds: Senior and junior (mezzanine/structured) debt and related capital for middle-market companies to support buyouts, recapitalizations, acquisitions, shareholder liquidity, and growth — deployed via Penfund Prime (senior) and Penfund Capital Fund VII (junior).
  • Size of company: Typically businesses generating at least ~US$20 million of annual EBITDA — i.e., established mid-market firms, not early-stage startups.
  • Check size: Large, concentrated positions — commitments up to C$225 million, and hold capacity up to ~C$300 million per transaction as a hold-to-maturity lender.
  • Company profile they favor: Asset-light businesses that convert 80–90% of EBITDA into free cash flow, frequently selling inexpensive, non-discretionary, non-deferrable consumable goods and services (resilient demand).
  • Sector stance: No fixed industry preference; the firm evaluates opportunities broadly across consumer, business services, healthcare, industrial, and financial-services end markets.
  • Style: Relationship-oriented and reliability-focused, emphasizing "speed, reliability, ease-of-use" and long-term partnership with private-equity sponsors and borrowers rather than short-hold trading of credit.

Notable Investments

  • DOCS Dermatology Group — US$205 million unitranche financing (announced March 2026) alongside Antares Capital and New Mountain to refinance and upsize the SkyKnight Capital–backed dermatology platform after six 2025 practice acquisitions.
  • Recochem — Participated (with CapVest and H.I.G.) in the acquisition/financing of Recochem, a global manufacturer of aftermarket transportation and household fluids (announced ~November 2023).
  • Arrowhead Engineered Products — Provided capital alongside Genstar Capital for Arrowhead, a distributor of aftermarket replacement parts; Penfund made an additional investment (~March 2022).

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.